SAN DIEGO--(BUSINESS WIRE)--Somaxon Pharmaceuticals, Inc. (NASDAQ: SOMX), a specialty pharmaceutical company, today announced that Richard W. Pascoe, Somaxon’s president and chief executive officer, is scheduled to present at the following investor conferences:
-
Monday, March 7, 2011
Cowen and Company 31st Annual Health Care Conference
The Boston Marriott Copley Place – Boston, MA
4:00 p.m. ET (1:00 p.m. PT) -
Monday, March 14, 2011
Roth 23rd Annual OC Growth Stock Conference
The Ritz Carlton – Laguna Niguel, CA
12:30 p.m. ET (9:30 a.m. PT) -
Wednesday, March 16, 2011
Barclays Capital 2011 Global Healthcare Conference
Loews Miami Beach Hotel – Miami, FL
3:45 p.m. ET (12:45 p.m. PT)
A live webcast of each presentation will be available in the Investor Relations section of the company’s Web site under Event Scheduler at www.somaxon.com. Each webcast will be accessible following conclusion of the live event and archived for approximately 90 days.
To be added to Somaxon Pharmaceuticals’ email list, please visit http://bit.ly/Somaxon-email-list.
About Somaxon Pharmaceuticals, Inc.
Headquartered in San Diego, CA, Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and of late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area. Somaxon’s product Silenor®, now available by prescription in the United States, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance.
For more information, please visit the company’s web site at www.somaxon.com.